Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 13 February 2020
      EFPIA & EFGCP Joint Report | Paediatric Workshop on Unmet Medical Needs
 
 
Reporting on the main outcomes
 
The objective behind the one-day workshop was to find a broadly accepted approach to defining unmet medical needs (UMN) among paediatric patients, in order to make better and safer medicines for children, and to make sure they are available and affordable.

By reading the report of the workshop you will see that the outcome was an outline of potential guiding principles for defining UMN in children, and a programme for testing the principles in selected therapeutic areas over the course of 2020.

Among the key recommendations were that, since no one-size-fits-all approach can work at present, progress should be made through addressing UMN by speciality, with an accent on treatment categories or gaps, but not on products.
Read more →
 
 
      The pharmaceutical industry in Europe calls for a Mutual Recognition Agreement on GMP in the context of EU-UK future relationship
 
  10 February 2020 EFPIA, Medicines for Europe and AESGP call for a Mutual Recognition Agreement on GMP in the...

The pharmaceutical industry in Europe has worked to support the EU27 and UK to reach an agreement that will allow patients...

Read more →
 
 
 
      Blogs
 
  10 February 2020 Animal use Statistics – Europe’s proactive approach in funding alternatives

The report on animal use statistics summarises the data on the use of animals in scientific procedures.

Read more →
 
 
 
  07 February 2020 Joining forces to improve the quality of life for children living with cancer

The VIK-e Program

Read more →
 
 
 
      Events
 
 
16 MAR 2020
  POSTPONED - China/EU Pharmaceutical Industry Forum 2020 Wavre, Belgium

** Event postponed until Autumn 2020 **

Learn more →
 
 
 
10 SEP 2020
  c4c Multi-Stakeholder Meeting on Child Psychiatry Brussels, Belgium

The first c4c Multi-Stakeholder Meeting on Child Psychiatry seeks to facilitate dialogue and provide an opportunity...

Learn more →
 
 
 
09 JUN 2020
  DIA Workshop on Optimising Variations Regulatory Framework Zagreb, Croatia

Towards EU Accession

Learn more →
 
 
 
14 MAY 2020
  10th European Conference on Rare Diseases & Orphan Products Virtual event

The upcoming ECRD 2020 will be held 100% online!

Learn more →
 
 
      What we are reading
ABPI response to proposed UK-‘Rest of the World’ FTA negotiation approaches 06 February 2020  (abpi.org) Read more →
Woman, mother, or working in healthcare? 29 January 2020  (IMI Conception) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe